Cell Line Development market in North America is expected to grow from US$ 1,393.32 Mn in 2019 to US$ 3,829.46 Mn by the year 2027. This represents a CAGR of 13.5% from the year 2020 to 2027.
The growth of the Cell Line Development market is driven by the factors such as increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes in the North America region.
The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.
Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America.
US is anticipated to lead the adoptions of cell line development across the North American region through the forecast period. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of cell line based end products such as precision medicine and other therapeutics is one of the major driving factors. In 2018, The All of Us Research Program of NIH funded the Genome Centers in generating genotype sequence data from bio samples. These factors are expected to accelerate market growth over the forecast years.
Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA CELL LINE DEVELOPMENT - MARKET SEGMENTATION
North America Cell Line Development Market - By Type
- Recombinant Cell Line
- Hybridomas
- Primary Cell Line
- Continuous Cell Lines
North America Cell Line Development Market - By Product
- Media and Reagent
- Equipment
North America Cell Line Development Market - By Application
- Bioproduction
- Drug Discovery
- Tissue Engineering
North America Cell Line Development Market - By Country
- U.S.
- Canada
- Mexico
Companies Mentioned
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- SELEXIS
- BioFactura, Inc.
- WuXi AppTec
- LakePharma, Inc.
- General Electric Company
- Lonza
- Corning Incorporated
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, By Product, Application, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Cell Line Development Market – Key Takeaways
3. North America Cell Line Development Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Cell Line Development Market – By Type
3.2.2 North America Cell Line Development Market – By Product
3.2.3 North America Cell Line Development Market – By Application
3.2.4 North America Cell Line Development Market – By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
4. North America Cell Line Development Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Research and Development Activities
4.1.2 Rising Incidence of Chronic Diseases
4.2 Key Market Restraints
4.2.1 Risk Associated with Cell Line Contamination
4.3 Key Market Opportunities
4.3.1 The Rise in Production of Biosimilars
4.4 Future Trends
4.4.1 Increasing Approvals of Gene/Cell Therapies
4.5 Impact Analysis
5. Cell Line Development Market – North America Analysis
5.1 North America Cell Line Development Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.3.1 Merck KGaA
5.3.2 Thermo Fisher Scientific Inc.
5.4 Expert Opinions
6. North America Cell Line Development Market Analysis – By Type
6.1 Overview
6.2 North America Cell Line Development Market, By Type, 2018 & 2027 (%)
6.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.4 Recombinant Cell Line Market
6.4.1 Overview
6.4.2 North America Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)
6.5 Hybridomas
6.5.1 Overview
6.5.2 North America Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
6.6 Primary Cell Line
6.6.1 Overview
6.6.2 North America Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
6.7 Continuous Cell Lines
6.7.1 Overview
6.7.2 North America Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America Cell Line Development Market Analysis – By Product
7.1 Overview
7.2 North America Cell Line Development Market, By Product, 2018 & 2027 (%)
7.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
7.4 Media And Reagent Market
7.4.1 Overview
7.4.2 North America Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)
7.5 Equipment
7.5.1 Overview
7.5.2 North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
8. North America Cell Line Development Market Analysis – By Application
8.1 Overview
8.2 North America Cell Line Development Market, By Application, 2018 & 2027 (%)
8.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
8.4 Bioproduction
8.4.1 Overview
8.4.2 North America Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)
8.5 Drug Discovery
8.5.1 Overview
8.5.2 North America Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
8.6 Tissue Engineering
8.6.1 Overview
8.6.2 North America Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)
9. North America Cell Line Development Market Revenue And Forecasts To 2027
9.1 Overview
9.2 North America Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.4 North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
9.5 North America Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.6 North America Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)
9.7 US Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.7.1 US Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.7.2 US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.7.3 US Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.7.4 US Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.8 Canada Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.8.1 Canada Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.8.3 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.8.4 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.9 Mexico Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.9.1 Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.9.2 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.9.3 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.9.4 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10. Cell Line Development Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in The Cell Line Development Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies in the Cell Line Development Market, 2016-2019
10.3.3 Expansion
10.3.3.1 Recent Expansion By Players In The Cell Line Development Market
10.3.4 Inorganic developments
10.3.5 Overview
10.3.6 Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019
10.3.7 Agreements
10.3.7.1 The Cell Line Development Market, By Agreements
10.3.8 Acquisitions
10.3.8.1 Acquisitions By Players In The Cell Line Development Market
11. Cell Line Development Market – Key Company Profiles
11.1 Merck KGaA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product /Services Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sartorius AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Selexis
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product/Service Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Biofactura, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Wuxi AppTec
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Service Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 LakePharma, Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 General Electric
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Lonza
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Information
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Corning Incorporated
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 2. North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
Table 3. North America Cell Line Development Market Revenue And Forecasts to 2027, By Applicayion (US$ Mn)
Table 4. North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
Table 6. North America Cell Line Development Market Revenue And Forecasts to 2027, By application (US$ Mn)
Table 7. US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9. US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10. Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 15. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 16. Recent Expansion in the Cell Line Development Market
Table 17. The Cell Line Development Market by Agreements
Table 18. Acquisitions in the Cell Line Development Market
Table 19. Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1. US Cell Line Development Market, Revenue (US$ Mn), By 2018 & 2027
Figure 2. North America Cell Line Development Market By Type Market Share (%), 2018
Figure 3. North America Cell Line Development Market By Product Market Share (%), 2018
Figure 4. North America Cell Line Development Market By Application Market Share (%), 2018
Figure 5. Cell Line Development Market Segmentation
Figure 6. North America PEST Analysis
Figure 7. Cell Line Development Market Impact Analysis Of Drivers & Restraints
Figure 8. North America Cell Line Development Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9. North America Cell Line Development Market, By Type, 2018 & 2027 (%)
Figure 10. North America Recombinant Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. North America Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. North America Primary Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. North America Continuous Cell Lines Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. North America Cell Line Development Market, By Product, 2018 & 2027 (%)
Figure 15. North America Media And Reagent Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. North America Cell Line Development Market, By Application, 2018 & 2027 (%)
Figure 18. North America Bioproduction Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. North America Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. North America Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. North America Cell Line Development Market Revenue, By Country, 2018 (US$ Mn)
Figure 22. North America Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. North America Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)
Figure 24. US Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Canada Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Mexico Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Growth Strategies in The Cell Line Development Market, (%)
Figure 28. Organic Growth Strategies In The Cell Line Development Market, 2016-2019
Figure 29. Inorganic Developments In The Cell Line Development Market, 2016-2019
The List of Companies - North America Cell Line Development Market
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- SELEXIS
- BioFactura, Inc.
- WuXi AppTec
- LakePharma, Inc.
- General Electric Company
- Lonza
- Corning Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For